4//SEC Filing
AMICUS THERAPEUTICS INC 4
Accession 0001209191-15-029051
$FOLDCIK 0001178879operating
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 9:50 PM ET
Size
18.3 KB
Accession
0001209191-15-029051
Insider Transaction Report
Form 4
Dilone Enrique
VP, Technical Operations
Transactions
- Exercise/Conversion
Common stock
2015-03-20$11.51/sh+14,045$161,669→ 64,045 total - Sale
Common srock
2015-03-20$11.51/sh−14,045$161,669→ 50,000 total - Exercise/Conversion
Stock Options (right to buy)
2015-03-20−2,812→ 42,188 totalExercise: $2.45From: 2015-01-03Exp: 2024-01-03→ Common stock (2,812 underlying) - Exercise/Conversion
Stock Options (right to buy)
2015-03-20−3,250→ 9,750 totalExercise: $4.16From: 2013-11-01Exp: 2019-11-16→ Common Stock (3,250 underlying) - Exercise/Conversion
Stock Options (right to buy)
2015-03-20−3,463→ 31,537 totalExercise: $2.52From: 2014-06-18Exp: 2023-06-18→ Common stock (3,463 underlying) - Exercise/Conversion
Stock Options (right to buy)
2015-03-20−1,896→ 33,104 totalExercise: $4.38From: 2013-06-04Exp: 2022-06-04→ Common stock (1,896 underlying) - Exercise/Conversion
Stock Options (right to buy)
2015-03-20−2,624→ 25,376 totalExercise: $3.53From: 2014-01-28Exp: 2023-01-28→ Common stock (2,624 underlying)
Footnotes (3)
- [F1]The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
- [F2]This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.17 to $11.90. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F3]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.17 to $11.90. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
AMICUS THERAPEUTICS INC
CIK 0001178879
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001178879
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 9:50 PM ET
- Size
- 18.3 KB